Payment overview · 2025
General Payments
$32.34
1 reported records · 1 companies
Healthcare provider profile · identity verified
Sandra T Labak, DO
Allopathic & Osteopathic Physicians|Family Medicine · HINCKLEY, IL · NPI 1396766218
Verified facts
What the public records show
CMS Open Payments records show Sandra T Labak, DO received $32.34 in general payments during 2025 across 1 reported records.
VERTEX PHARMACEUTICALS INCORPORATED accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $32.34 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.34 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $32.34 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 360 | 51 |
| Levothyroxine Sodium | Levothyroxine Sodium | 311 | 35 |
| Gabapentin | Gabapentin | 305 | 37 |
| Furosemide | Furosemide | 279 | 33 |
| Eliquis | Apixaban | 258 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 248 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 233 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 230 | 26 |
| Lisinopril | Lisinopril | 221 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 209 | 31 |
| Amlodipine Besylate | Amlodipine Besylate | 181 | 30 |
| Potassium Chloride | Potassium Chloride | 180 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 176 | 19 |
| Metoprolol Succinate | Metoprolol Succinate | 127 | 18 |
| Trazodone Hcl | Trazodone Hcl | 117 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 112 | suppressed |
| Losartan Potassium | Losartan Potassium | 109 | 19 |
| Donepezil Hcl | Donepezil Hcl | 101 | 12 |
| Finasteride | Finasteride | 101 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 97 | 21 |
| Mirtazapine | Mirtazapine | 97 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 92 | 12 |
| Pantoprazole Sodium | Pantoprazole Sodium | 92 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 79 | suppressed |
| Baclofen | Baclofen | 78 | suppressed |
| Carvedilol | Carvedilol | 78 | 11 |
| Xarelto | Rivaroxaban | 78 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | suppressed |
| Metformin Hcl | Metformin Hcl | 67 | 15 |
| Pregabalin | Pregabalin | 64 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 63 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 62 | 15 |
| Divalproex Sodium | Divalproex Sodium | 59 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 58 | suppressed |
| Jardiance | Empagliflozin | 57 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 57 | 18 |
| Allopurinol | Allopurinol | 55 | suppressed |
| Scopolamine | Scopolamine | 55 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 52 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 52 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 51 | suppressed |
| Lorazepam | Lorazepam | 51 | 11 |
| Alendronate Sodium | Alendronate Sodium | 50 | suppressed |
| Alprazolam | Alprazolam | 49 | 17 |
| Cephalexin | Cephalexin | 49 | suppressed |
| Novolog Flexpen | Insulin Aspart | 48 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 48 | suppressed |
| Lactulose | Lactulose | 46 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 45 | suppressed |
| Levetiracetam | Levetiracetam | 44 | suppressed |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 44 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 43 | suppressed |
| Risperidone | Risperidone | 43 | suppressed |
| Omeprazole | Omeprazole | 42 | 12 |
| Tramadol Hcl | Tramadol Hcl | 42 | 17 |
| Bupropion Xl | Bupropion Hcl | 41 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 41 | suppressed |
| Clonazepam | Clonazepam | 38 | suppressed |
| Spironolactone | Spironolactone | 36 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 35 | suppressed |
| Famotidine | Famotidine | 34 | suppressed |
| Ozempic | Semaglutide | 34 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 33 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 33 | suppressed |
| Pentoxifylline | Pentoxifylline | 33 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 33 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 33 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | suppressed |
| Metolazone | Metolazone | 30 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 30 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 23 |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Fentanyl | Fentanyl | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Haloperidol | Haloperidol | 26 | suppressed |
| Verapamil Er | Verapamil Hcl | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 25 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Calcitriol | Calcitriol | 24 | suppressed |
| Januvia | Sitagliptin Phosphate | 24 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Amantadine | Amantadine Hcl | 23 | suppressed |
| Latanoprost | Latanoprost | 23 | suppressed |
| Nystop | Nystatin | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Nystatin | Nystatin | 22 | 14 |
| Bumetanide | Bumetanide | 21 | suppressed |
| Atenolol | Atenolol | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 19 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 19 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Simvastatin | Simvastatin | 19 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 18 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Azathioprine | Azathioprine | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Entecavir | Entecavir | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Renacidin | Citric Ac/Gluconolact/Mag Carb | 12 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Budesonide | Budesonide | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.34 · 1 records | VERTEX PHARMACEUTICALS INCORPORATED | JOURNAVX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error